REG - Genus - Chief Executive Officer Retirement

GenusAnnouncement

23/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230223:nRSW7632Qa&default-theme=true

RNS Number : 7632Q  Genus PLC  23 February 2023

For Immediate Release
 
23 February 2023

 

Genus plc

('Genus', or the 'Company')

Chief Executive Officer Retirement

 

Genus plc (LSE: GNS), a leading global animal genetics company, announces
that Stephen Wilson, Chief Executive, has informed the Board of his intention
to retire after ten years with the Company, the last four of which as Chief
Executive Officer.  Stephen has committed to remain with Genus until 30
September 2023 in order to achieve a smooth transition to a successor, while
continuing to drive business strategy and performance.

A formal search for Stephen's successor has been initiated with an executive
search agency and a further announcement will be made in due course.

On behalf of the Board, Iain Ferguson, the Chairman of Genus commented;

"During Stephen's time at Genus, including six years as Chief Financial
Officer and four years as Chief Executive, the Company has made great
strategic progress as a world-leading animal genetics company, making great
strides in its vision to sustainably pioneer animal genetic improvement to
help nourish the world.

"Stephen has overseen significant investment in the Group to support its long
term strategic growth. These contributions have included the global launch of
Sexcel, the significant strengthening of the Group's Research and Development
 capabilities,  the ongoing PRRSv development programme, driving the
Company's digital transformation, energising the Company's sustainability
focus, broadening our geographic focus including growth in India and China,
and investing in best in class animal facilities around the world.  Stephen
will leave the Company in excellent shape with a world-class leadership team,
world-class genetics, and a growing innovation platform to enable the company
to pursue many exciting future opportunities. Stephen has provided the Company
with many years of strong leadership, and the Board and I remain excited by
the Company's prospects. On behalf of the Board and all at Genus, I would like
to thank Stephen for his commitment to the Company and his significant
contributions to its success."

Stephen Wilson added "It has been a great privilege to lead such a talented
group of people and develop a leading global agricultural biotechnology
business with sustainability at the very heart of its development
activities.  After four years as Chief Executive and ten years as an
executive director, I believe now is the right time for me to move to the next
phase of my life. Genus has many strong growth opportunities, and I will
remain fully focused on the continued successful execution of our strategy
while the Board progresses the search for my successor."

 Genus                                        Tel: +44(0)1256 345970
 Iain Ferguson, Chair

Alison Henriksen, Chief Financial Officer
 Buchanan                                     Tel: +44(0)207 466 5000
 Charles Ryland / Chris Lane / Verity Parker

This announcement is available on the Genus website www.genusplc.com
(http://www.genusplc.com/)

About Genus

Genus is a world-leading animal genetics company. Genus creates advances to
animal breeding and genetic improvement by applying biotechnology and sells
added value products for livestock farming and food producers. Its technology
is applicable across livestock species and is currently commercialised by
Genus in the dairy, beef and pork food production sectors.

Genus's worldwide sales are made in over seventy-five countries under the
trademarks 'ABS' (dairy and beef cattle) and 'PIC' (pigs) and comprise semen,
embryos and breeding animals with superior genetics to those animals currently
in farms. Genus's customers' animals produce offspring with greater production
efficiency, and quality, and use these to supply the global dairy and meat
supply chains.

The Group's competitive edge has been created from the ownership and control
of proprietary lines of breeding animals, the biotechnology used to improve
them and its global supply chain, technical service and sales and distribution
network.

With headquarters in Basingstoke, United Kingdom, Genus companies operate in
over twenty-five countries on six continents, with research laboratories
located in Madison, Wisconsin, USA.

Regulatory Notes

Details of Stephen Wilson's terms of departure are still to be finalised. Any
such terms will be consistent with the Company's approved Directors
Remuneration Policy. Details of any payments to be made to Stephen will be
posted on the Company's website, in accordance with section 430(2B) Companies
Act 2006.

 

This announcement contains inside information for the purposes of Article 7 of
Regulation 596/2014.  The person responsible for making this announcement on
behalf of the Group is Dan Hartley (General Counsel and Company Secretary).

 

This announcement is made in accordance with Listing Rule 9.6.11R.   There
are no matters to be disclosed in connection with Listing Rule 9.6.13R (2) -
(6).

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEAXAAALEDEFA